300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Oman
Cameroon
Colombia
Australia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Moldova
United Kingdom
Seychelles
Botswana
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
United States
Ireland
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in Canada (July 2026)

The most active venture capital funds investing in Canada Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Canada Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
FACIT
VC Fund
9 Canada, United States Seed, Pre-Seed Biotechnology, Health Care, Medical Device $1.5M–$8M
Real Ventures
VC Fund
6 Canada, United States, United Kingdom Seed, Series A, Series B Software, Artificial Intelligence, Machine Learning $650k–$50M
E-Fund
VC Fund
5 Canada, China, United States Seed, Pre-Seed Health Care, Medical, Medical Device $256k–$4.2M
Amplitude Venture Capital
VC Fund
5 Canada, United States, Israel Series B, Series A, Seed Biotechnology, Health Care, Therapeutics $2.9M–$142M
Ontario Centre of Innovation
VC Fund
4 Canada, United States Seed, Pre-Seed, Grant Health Care, Medical, Software $7.3k–$3.2M
Anges Quebec
VC Fund
4 Canada, Spain, United States Seed, Angel Software, Health Care, Artificial Intelligence $366k–$3.2M
Apjohn ventures
VC Fund
4 United States, Canada Series A, Series C Health Care, Biotechnology, Life Science $2.5M–$39M
Radical Ventures
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Artificial Intelligence, Software, Information Technology $2M–$200M
Golden Ventures
VC Fund
3 Canada, United States, United Kingdom Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.5M–$47M
Innovacorp
VC Fund
3 Canada, Australia, United States Seed, Grant, Pre-Seed Software, Information Technology, Health Care $18k–$3.1M
Afore Capital
VC Fund
3 United States, Canada, India Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$23M
Fonds de solidarité FTQ
VC Fund
3 Canada, United States, Israel Series A, Series B Manufacturing, Biotechnology, Software $6.3M–$75M
Atlantic Canada Opportunities Agency
VC Fund
3 Canada, United States, France Grant, Debt Financing, Seed Software, Manufacturing, Health Care $25k–$2M
MEDTEQ+
VC Fund
3 Canada, United States Seed, Series A Health Care, Medical Device, Biotechnology $1.5M–$18M
Panache Ventures
VC Fund
3 Canada, United States, Israel Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $717k–$20M
Toronto Innovation Acceleration Partners
VC Fund
3 Canada, United States Pre-Seed, Seed Health Care, Biotechnology, Software $22k–$8M
GreenSky Ventures
VC Fund
3 Canada, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $731k–$4.5M
iGan Partners
VC Fund
3 Canada, United States, Israel Seed, Series A Health Care, Software, Medical $1.9M–$17M
Yaletown Partners
VC Fund
2 Canada, United States, Belgium Series A, Series B, Seed Software, Enterprise Software, Manufacturing $603k–$54M
Hazelview Ventures
VC Fund
2 Canada, Slovakia (Slovak Republic) Seed, Pre-Seed, Venture - Series Unknown Software, Artificial Intelligence, Big Data $2M–$12M
Alexandria Venture Investments
VC Fund
2 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Archangel Network of Funds
VC Fund
2 Canada, United States Seed, Pre-Seed Health Care, Software, Medical $695k–$3.1M
Charles River Laboratories International
VC Fund
2 United States, Canada, France Series A, Series B Biotechnology, Health Care, Life Science $12M–$103M
Theodorus III
VC Fund
2 Belgium, Canada, France Seed, Series A Health Care, Life Science, Biotechnology $2.2M–$18M
WUTIF
VC Fund
2 Canada Seed, Pre-Seed, Series A Software, Health Care, Biotechnology $100k–$3.8M
Ontario Centres of Excellence
VC Fund
2 Canada, United States Seed, Grant, Pre-Seed Software, Information Technology, Health Care
Breakwater Ventures
VC Fund
2 United States Seed, Venture - Series Unknown Financial Services, Credit, FinTech $1.2M–$9M
Accelerate Fund
VC Fund
2 Canada, United States Seed, Series A Software, Health Care, Medical $951k–$12M
Sustainable Development Technology Canada
VC Fund
2 Canada, United States, Brazil Grant, Seed Energy, Manufacturing, Software $73k–$6.5M
BDC Venture Capital
VC Fund
2 Canada, United States, Japan Series A, Seed Software, Information Technology, Artificial Intelligence $603k–$17M
Page One Ventures
VC Fund
2 United States, Canada, United Kingdom Seed, Pre-Seed, Series B Software, Artificial Intelligence, Information Technology $500k–$130M
Resolve Growth Partners
VC Fund
2 United States, Canada Series A, Series B, Venture - Series Unknown Software, SaaS, Information Technology $7M–$21M
Versant Ventures
VC Fund
2 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $4.7M–$108M
Ramen Ventures
VC Fund
2 Canada, United States Seed, Pre-Seed, Angel Biotechnology, Health Care, Software $120k–$3.2M
ScaleGood Fund LP (powered by TELUS)
VC Fund
2 Canada Seed, Pre-Seed Health Care, Wellness, Apps $37k–$8.7M
Pfizer Venture Investments
VC Fund
2 United States, United Kingdom, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$123M
Desjardins Venture Capital
VC Fund
2 Canada, United States Seed, Series A Software, Information Technology, Manufacturing $805k–$22M
LVL1 Group
VC Fund
2 Canada, United States, United Kingdom Seed, Series A, Series B Software, Health Care, Apps $577k–$39M
Innovate Calgary
VC Fund
2 Canada, United States Seed, Pre-Seed Health Care, Medical, Medical Device $76k–$1.9M
Angel Forum
VC Fund
2 Canada, United States Seed, Angel, Pre-Seed Biotechnology, Software, Health Care $20k–$500k
Two Small Fish Ventures
VC Fund
2 Canada, United States, Trinidad and Tobago Seed, Series A Software, Artificial Intelligence, E-Commerce $1.8M–$25M
StandUp Ventures
VC Fund
2 Canada, United States Seed, Series A, Pre-Seed Software, SaaS, Artificial Intelligence $731k–$14M
Sandpiper Ventures
VC Fund
1 Canada, United States Seed, Series A, Pre-Seed Software, Wellness, Productivity Tools
Orchard Venture Partners
VC Fund
1 United States, Canada, United Kingdom Series B, Series A Biotechnology, Therapeutics, Health Care
Biofund
VC Fund
1 Canada, Denmark, Russian Federation Seed Genetics, Medical, Health Care
Rhino Ventures
VC Fund
1 Canada, United States, Isle of Man Seed, Series A, Series B Financial Services, Software, FinTech
Spaceship
VC Fund
1 Canada, Portugal, United States Seed, Series A Blockchain, Credit, Content
Rho Canada Ventures
VC Fund
1 Canada, United States, Italy Series A, Series B, Seed Software, Analytics, Internet
National Research Council of Canada Industrial Research Assistance Program
VC Fund
1 Canada, Norway, Denmark Grant, Seed Biotechnology, Software, Health Care
Octane
VC Fund
1 Canada Pre-Seed Life Science, Biotechnology
Access all 277 VC funds in Canada Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

FACIT
VC Fund · Toronto, Ontario, Canada · 9 investments in Canada Life Science startups

We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 31
  • Round size: Seed $1.5M–$8M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
  • Hyivy Health — Hyivy Health is working on the first smart pelvic health rehabilitation system for patients and the clinicians who treat them.
  • HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
Show all investments...

Real Ventures
VC Fund · Montréal, Quebec, Canada · 6 investments in Canada Life Science startups

Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 209
  • Round size: Seed $650k–$5M; Series A $2.2M–$22M; Series B $7M–$50M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $132M in 2017

Portfolio highlights

  • BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
  • Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
  • SPARK Microsystems — SPARK UWB Technology enables ultra-low-latency, high-speed wireless for AI glasses, spatial computing, gaming, audio, and IoT devices.
Show all investments...

E-Fund
VC Fund · Vancouver, Alberta, Canada · 5 investments in Canada Life Science startups

The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Canada, China, United States

Investor stats

  • Total investments: 57
  • Round size: Seed $474k–$4.2M; Pre-Seed $256k–$1M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Qase — Qase is a B2B SaaS platform that reinvents how law firms and legal organizations manage legal referrals.
  • ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
  • CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
Show all investments...

Amplitude Venture Capital
VC Fund · Montréal, Quebec, Canada · 5 investments in Canada Life Science startups

Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Seed
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 36
  • Round size: Seed $6.6M–$18M; Series A $2.9M–$85M; Series B $35M–$142M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $146M in 2019

Portfolio highlights

  • Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Show all investments...

Ontario Centre of Innovation
VC Fund · Toronto, Ontario, Canada · 4 investments in Canada Life Science startups, 16 in the past 12 months

Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Pre-Seed, Grant
  • Geography: Canada, United States

Investor stats

  • Total investments: 52
  • Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $146k–$2.3M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Synakis — Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous.
  • Medtech Canada — Medtech Canada provides safe and innovative medical technologies solutions.
  • Kare Chemical Technologies — Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
Show all investments...

Anges Quebec
VC Fund · Quebec, Quebec, Canada · 4 investments in Canada Life Science startups

Value-added investors for innovative entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Angel
  • Geography: Canada, Spain, United States

Investor stats

  • Total investments: 159
  • Round size: Seed $805k–$3.2M; Angel $366k–$1.3M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Zilia — Zilia's non-invasive assessment of biomarkers in the eye redefines the way we prevent, diagnose, and treat various diseases.
  • Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
  • Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
Show all investments...

Apjohn ventures
VC Fund · Kalamazoo, Michigan, United States · 4 investments in Canada Life Science startups

Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstandinggrowth potential.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Series A, Series C
  • Geography: United States, Canada

Investor stats

  • Total investments: 15
  • Round size: Series A $2.5M–$39M; Series C $3M–$34M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Tetra Discovery — Tetra Discovery Partners provides consulting services in drug discovery and development. They partner with Universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system.Their research focuses on developing new treatments for depression and schizophrenia. Severe forms ofdepression affect 2–5% of the US population, while mood disorders impact 7% of the world’s population and rank among the top ten causes of disability.
  • Tetra Therapeutics — Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders.
  • Sierra Oncology — Sierra Oncology is late-stage clinical drug development biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.
Show all investments...

Radical Ventures
VC Fund · Toronto, Ontario, Canada · 4 investments in Canada Life Science startups

Radical Ventures invests in the future of how we live, work and play, partnering with founders who understand the transformational power of AI.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 124
  • Round size: Seed $2M–$27M; Series A $7M–$53M; Series B $30M–$200M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
  • Generalist AI — At Generalist, we are on a mission to make general-purpose robots a reality.
  • Orbital Industries — Orbital Materials leverages AI to design and deploy advanced materials & climate technologies for the long-term habitability of our planet.
Show all investments...

Golden Ventures
VC Fund · Toronto, Ontario, Canada · 3 investments in Canada Life Science startups

Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 184
  • Round size: Seed $1.5M–$7.5M; Series A $5.9M–$32M; Series B $14M–$47M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Forma.ai — Forma.ai's sales performance management software brings comp strategy and execution into one platform, and acts as a single source of truth for sales performance.
  • Event — Meet Buildable - the place where top developers at world-class companies go to achieve microservice maturity. Use our low-code editor to build, test and deploy web apps in a matter of minutes.
  • Mangrove Systems — Mangrove Systems helps critical carbon projects track their impact so they can build trust with their partners, customers, and communities using leading carbon measurement and monitoring infrastructure.
Show all investments...

Innovacorp
VC Fund · Halifax, Nova Scotia, Canada · 3 investments in Canada Life Science startups

Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Canada, Australia, United States

Investor stats

  • Total investments: 155
  • Round size: Seed $50k–$3.1M; Grant $25k–$91k; Pre-Seed $18k–$878k
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
  • Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
  • CarbonCure Technologies — CarbonCure Technologies creates, develops, and licenses solutions that consume waste CO2 to make better concrete. It spurs the market shift towards affordable green concrete, by enabling concrete manufacturers to convert waste CO2 into solid minerals, locked away as a solid within concrete during manufacturing. It is a green building technologycompany currently serving concrete product manufacturers in the US and Canada. It offers concrete producers the ability to manufacture green concrete products without compromising on either quality or price.CarbonCure is a retrofit innovation that repurposes CO2 gas from large final emitters as a feedstock in concrete plants. The gas is permanently converted into embedded solid mineral carbonates that yield material, environmental, and production advantages. By enabling concrete manufacturers to consume CO2 into concrete products during manufacturing, the technology differentiates an otherwise traditional commodity concrete product, while achieving superior material performance characteristics. In addition to technology, CarbonCure provides demand-pull marketing and environmental reporting/certification services to reinforce its customers’ exclusive competitive positioning. The technology is licensed at a very low-CAPEX to concrete producers, generating a recurring revenue stream.CarbonCure Technologies was founded in 2007 and is headquartered in Halifax, Nova Scotia.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Afore Capital
VC Fund · San Francisco, California, United States · 3 investments in Canada Life Science startups

Afore Capital backs product-centric founders at the pre-seed stage exclusively. The investment team brings 16 years of founding product experience (Android and Twitter) and 7 years of institutional investing experience (Founder Collective and Foundation Capital). Their sweet spot is the ~$1M pre-seed round, where they can lead the round as aninstitutional investor alongside high value angels.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 217
  • Round size: Seed $2.2M–$10M; Pre-Seed $500k–$3.2M; Series A $7M–$23M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Aemon — Aemon builds an AI system that reads code and research, runs experiments, and improves engineering solutions against defined tests.
  • BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
  • Mesh — Business entity identity verification radically simple, trusted, and portable, ensuring seamless interactions in the B2B Ecommerce, Marketplaces, Real Estate Technology, Construction | Mesh.
Show all investments...

Fonds de solidarité FTQ
VC Fund · Montréal, Quebec, Canada · 3 investments in Canada Life Science startups

Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Software
  • Stage:Series A, Series B
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 222
  • Round size: Series A $6.3M–$46M; Series B $7.5M–$75M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Cook it — Cook it is a ready-to-cook meal company in Canada. Cook it's mission is to reduce food waste and to take away the inconvenience associated with weekly meal planning. The company delivers incredibly delicious and easily prepared meals that everyone can proudly cook.
  • Carbicrete — CarbiCrete is a carbon removal technology company that enables the production of cement-free, decarbonized concrete.
  • Flare — Flare equips your team to shut down cybercrime before it escalates. Detect, prioritize, and remediate external cyber threats with automated Threat Exposure Management.
Show all investments...

Atlantic Canada Opportunities Agency
VC Fund · Moncton, New Brunswick, Canada · 3 investments in Canada Life Science startups, 65 in the past 12 months

The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians,we are building a stronger economy.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Grant, Debt Financing, Seed
  • Geography: Canada, United States, France

Investor stats

  • Total investments: 207
  • Round size: Seed $25k–$2M; Grant $33k–$2M; Debt Financing $141k–$1.1M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • SudDrop — SudDrop Laundry Services offers convenient on-demand laundry pickup and delivery for homes and businesses.
  • IGNITE — Ignite assists entrepreneurs at all stages, whether they are beginning a firm, growing it, or maintaining long-term success.Ignite has been leading an innovative and knowledge-based strategy to help individuals thrive and businesses prosper.
  • The Halifax Honey — The Halifax Honey is a manufacturing company that provides sweet and spicy condiments made from wildflower honey and real chili peppers.
Show all investments...

MEDTEQ+
VC Fund · Montreal, Quebec, Canada · 3 investments in Canada Life Science startups

MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 32
  • Round size: Seed $1.5M–$4M; Series A $2.9M–$18M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • Eli — At-home hormone testing from Eli Health: track cortisol, progesterone, and testosterone with saliva tests that deliver lab-grade results in 20 minutes.
  • NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
  • Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
Show all investments...

Panache Ventures
VC Fund · Montréal, Quebec, Canada · 3 investments in Canada Life Science startups

Canada's leading nationwide pre-seed venture fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 152
  • Round size: Seed $1M–$6M; Pre-Seed $717k–$2.8M; Series A $5.7M–$20M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Lotly — Find your best mortgage rate in a few clicks with our mortgage discovery system. Whether you're a first time homebuyer, looking to refinance, or require a creative solution, our mortgage agents will help with every step. Expert advice, personalized results, and the best experience at no cost to you.
  • PainWorth — Assess, calculate and settle your injury claim online. For free. Our automated system is faster, fairer, easier and stress-free with full transparency on every step. Resolve your injury claim now.
  • CYBERNETIQ — Identify real-time threats others can't see, and get complete visibility of your network with a military-grade attack surface analysis tool.
Show all investments...

Toronto Innovation Acceleration Partners
VC Fund · Toronto, Ontario, Canada · 3 investments in Canada Life Science startups

MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Pre-Seed, Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 66
  • Round size: Seed $73k–$8M; Pre-Seed $22k–$525k
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
  • Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
  • Grey Matter Neurosciences — Grey Matter Neurosciences is a neurotechnology firm developing new medical devices and drug-device combinations to treat age-related brain illnesses like dementia.
Show all investments...

GreenSky Ventures
VC Fund · Toronto, Ontario, Canada · 3 investments in Canada Life Science startups

GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 65
  • Round size: Seed $731k–$3.3M; Series A $1.1M–$4.5M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Derapi — Derapi is a universal API for distributed energy resource (DER) devices, including solar, battery storage, EV chargers, smart thermostats, heat pumps, and other behind-the-meter loads. Derapi unlocks the full value of DERs by removing bottlenecks related to data integration, reducing data infrastructure costs and speeding time to market for DERsoftware developers, DER device manufacturers, and others in the DER ecosystem.
  • GridBank — GridBank is a vertical video UGC library for brands that want ready-made social content without managing creators directly. It offers royalty-free, social-native videos you can search in natural language and download for use in organic and paid campaigns.
  • Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
Show all investments...

iGan Partners
VC Fund · Toronto, Ontario, Canada · 3 investments in Canada Life Science startups

iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 49
  • Round size: Seed $1.9M–$5M; Series A $4M–$17M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
  • Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
  • Adenocyte — Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor.
Show all investments...

Yaletown Partners
VC Fund · Vancouver, British Columbia, Canada · 2 investments in Canada Life Science startups

Yaletown Partners specializes in investing in software, data, and device technologies. It invests in technology companies that improve industry and enterprise productivity and sustainability, to help accelerate their growth, shorten exit timeframes, and accomplish strong exit premiums.With offices in Vancouver, Calgary, Montréal, and a growingpresence in Toronto, Yaletown is led by a national team that contributes almost 100 years of technology-industry experience and a network of extensive industry relationships.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Manufacturing
  • Stage:Series A, Series B, Seed
  • Geography: Canada, United States, Belgium

Investor stats

  • Total investments: 90
  • Round size: Seed $603k–$5.2M; Series A $2.9M–$16M; Series B $2.1M–$54M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2017

Portfolio highlights

  • GHGSat — GHGSat’s mission is to become the global reference for remote sensing of greenhouse gas (GHG), air quality gas, and other trace gas emissions from any source in the world.In June 2016, GHGSat launched the world’s first high-resolution satellite capable of measuring greenhouse gas (CO2 & CH4) emissions from any industrial facility in theworld. GHGSat is using this unique satellite and its patented technology to provide greenhouse gas emissions monitoring data and services globally,with better accuracy and at at a fraction of the cost of comparable alternatives. Owners of industrial facilities are now able to monitor all of their facilities, local or remote, anywhere in the world, with a common technology, in near-real-time. Significantly improved emissions information is enabling industries to better measure, control, and ultimately reduce emissions of GHGs.Building on lessons learned from its demonstration satellite, GHGSat launched its second satellite in Sept 2020 and a third is scheduled for Q1'21. Three more satellites are under construction for launch in early 2022. GHGSat also uses the same instrument technology from its satellites on aircraft, to provide complementary resolution and performance for customers in shale plays. GHGSat’s technology can also be used to monitor air quality gases, as well as other trace gases, in the atmosphere. Business cases are being developed for key markets, such as measuring SOx from ships.
  • Oloid — Frictionless and secure passwordless authentication for frontline workers enabling modern cybersecurity and identity and access management for deskless workers and shared devices.
  • Nanoprecise Sci Corp — Predictive Maintenance, Automated Ai Based Predictive Maintenance, Machine Doctor, Wireless Industrial Iot Sensors, Artificial Intelligence in Maintenance, Scaling Iot Solutions
Show all investments...

Hazelview Ventures
VC Fund · Toronto, Ontario, Canada · 2 investments in Canada Life Science startups

Hazelview Ventures provide entrepreneurs with a unique opportunity to refine, scale, and showcase product and service capabilities.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Big Data
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Canada, Slovakia (Slovak Republic)

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$12M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • Xaba — Xaba develops intelligent automation solutions, materials and processes to enable a world of sustainable manufacturing.
  • Lamarr.AI — Saving Energy Through Automated Building Exterior Inspection AI-powered envelope diagnostics to accelerate the transition to Net Zero buildings. Contact Us About Lamarr.AI Defining pathways for future cities by developing technology innovations Lamarr.AI entered the market in 2023 as the product
  • SensorSuite — A Complete Suite Of Monitoring And Control Solutions For Your Boilers & Electrically Heated Buildings
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 2 investments in Canada Life Science startups

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 262
  • Round size: Seed $2M–$31M; Series A $12M–$101M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
  • Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
  • CREATE Medicines — Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyteapproach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.
Show all investments...

Archangel Network of Funds
VC Fund · Kitchener, Ontario, Canada · 2 investments in Canada Life Science startups

Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 42
  • Round size: Seed $695k–$3.1M; Pre-Seed $700k–$1.6M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Mesosil — Mesosil develops responsive antimicrobial materials to prevent infection at the medical device-tissue interface, with lifetime length of effect. Our technology is ideally suited for dental restoratives and dental implant surfaces. The result is greatly improved patient outcome with no change to practitioner workflow, reducing the likelihood ofrecurrent caries and detachment of dental restorations, or peri-implant wound infection that could result in implant loss and implant revision.
  • TimeSmart.AI — TimeSmart.AI provides a comprehensive solution developed with the guidance of physicians and compliance professionals to help improve organizational efficiencies.TimeSmart.AI delivers a robust, all-in-one solution crafted with input from physicians and compliance experts. It streamlines organizational workflows to boost efficiencies acrosshealthcare operations. Designed for real-world reliability, it helps teams save time while upholding the highest standards of care and regulation.
  • IRegained Inc. — IRegained develops an in-home digital rehabilitation system to rewire the brain through the power of neuroplasticity, empowering stroke and traumatic brain injury survivors to reclaim unassisted use of their hands.
Show all investments...

Charles River Laboratories International
VC Fund · Wilmington, Massachusetts, United States · 2 investments in Canada Life Science startups

Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 14
  • Round size: Series A $20M–$31M; Series B $12M–$103M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
  • Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
  • Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Show all investments...

Theodorus III
VC Fund · 2 investments in Canada Life Science startups

Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed, Series A
  • Geography: Belgium, Canada, France

Investor stats

  • Total investments: 15
  • Round size: Seed $3.7M–$18M; Series A $2.2M–$6.6M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
  • Simmunome AI — We use AI to create accurate, comprehensive disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to gain insights, make go/no-go decisions, and de-risk your pipeline, getting you to market faster and reducing your R&D co
  • Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
Show all investments...

WUTIF
VC Fund · Vancouver, British Columbia, Canada · 2 investments in Canada Life Science startups

WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Canada

Investor stats

  • Total investments: 73
  • Round size: Seed $100k–$3.8M; Pre-Seed $256k–$1.2M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
  • Carbonyx — Carbonyx is a biotechnology company that transforms industrial waste into valuable byproducts while permanently storing carbon dioxide.
  • CereCura Nanotherapeutics — CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.
Show all investments...

Ontario Centres of Excellence
VC Fund · Toronto, Ontario, Canada · 2 investments in Canada Life Science startups

The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 150
  • Lead/follow: no public data

Portfolio highlights

  • Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
  • FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
  • Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
Show all investments...

Breakwater Ventures
VC Fund · Seattle, Washington, United States · 2 investments in Canada Life Science startups

Pre-seed investment fund focused on the PNW, Western Canada, and beyond.

Show more...

Investment focus

  • Industry: Financial Services, Credit, FinTech
  • Stage:Seed, Venture - Series Unknown
  • Geography: United States

Investor stats

  • Total investments: 9
  • Round size: Seed $1.2M–$9M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Gone — Gone is a goods redistribution platform that offers free pickup of gently used household products.
  • Scispot — Connect your research, inventory, & sample data. Automate your workflows with a no-code toolkit. Track & manage your projects. Collaborate & document with your team & partners. All in one spot. Go beyond old-school ELN and LIMS systems.
  • Confido Legal — Confido Legal provides a credit/debit card and ACH payment processing platform specifically designed for law firms and legal technology companies. The platform offers features such as automated payment plans, payment pages for firm websites, and integration with financial management tools like QuickBooks Online. Confido Legal aims to enhancefinancial flexibility for law firms, ensuring they never have to turn away clients due to payment issues.
Show all investments...

Accelerate Fund
VC Fund · Calgary, Alberta, Canada · 2 investments in Canada Life Science startups

Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 59
  • Round size: Seed $1M–$6.6M; Series A $951k–$12M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2020

Portfolio highlights

  • Dryrun — From lightening fast data imports and automated forecasts, through to unmatched control to model out scenarios, Dryrun is the choice for CFOs managing cash flow for multi-million dollar businesses. Dryrun integrates with Sage Intacct, QuickBooks Online, Xero and Pipedrive.
  • Fairly Staffing — On demand shift filling platform for dental offices and dental professionals.
  • Chroma Technologies — Chroma Technologies provides financial technology and property solutions to enhance the rental experiences.
Show all investments...

Sustainable Development Technology Canada
VC Fund · Ottawa, Ontario, Canada · 2 investments in Canada Life Science startups

At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.

Show more...

Investment focus

  • Industry: Energy, Manufacturing, Software
  • Stage:Grant, Seed
  • Geography: Canada, United States, Brazil

Investor stats

  • Total investments: 185
  • Round size: Seed $73k–$1.7M; Grant $878k–$6.5M
  • Lead/follow: 77% lead, 23% follow

Portfolio highlights

  • Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
  • Prairie Robotics — Leading smart camera solutions for sustainable recycling and waste management.
  • Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
Show all investments...

BDC Venture Capital
VC Fund · Calgary, Alberta, Canada · 2 investments in Canada Life Science startups

BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Seed
  • Geography: Canada, United States, Japan

Investor stats

  • Total investments: 408
  • Round size: Seed $603k–$5M; Series A $3.3M–$17M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Expeto — Expeto is the world’s first and market leading “carrier-grade” Private Mobile Networking (PMN) platform that allows enterprises to confidently extend public and private mobile networks as one secure corporate WAN without losing control of their data or devices. Unlike hardware-heavy legacy solutions, Expeto is a containerized, software solutionpurpose-built to install behind the firewall, from the cloud, at the edge, or on prem. Affordably offered “as-a-service” and easily managed by IT, Expeto is as easy to deploy and manage as a Wi-Fi network.
  • Axonify — Axonify provides eLearning software, interval reinforcement solutions, and gamified learning. Using principles of interval reinforcement and incorporating the realities of how emerging workforces learn in today’s environment, Axonify enables its customers to make training stick and improve employee performance.
  • Optessa — Optimize factory operations and multi-factory supply chains through solutions that enable the future of complex manufacturing.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Page One Ventures
VC Fund · San Francisco, California, United States · 2 investments in Canada Life Science startups

Next-generation venture capital. Write your story with us.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 83
  • Round size: Seed $3M–$23M; Pre-Seed $500k–$5M; Series B $24M–$130M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Stuut — Improve DSO and reduce your outstanding cash balance with AI agents that power workflows from invoice creation through cash application.
  • Snowcap Compute — Snowcap Compute develops advanced artificial intelligence computing chips that leverage superconducting technology for faster processing and greater energy efficiency.
  • Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.
Show all investments...

Resolve Growth Partners
VC Fund · Baltimore, Maryland, United States · 2 investments in Canada Life Science startups

Enabling passionate, committed SaaS entrepreneurs to accelerate growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada

Investor stats

  • Total investments: 19
  • Round size: Series A $7.5M–$21M; Series B $17M–$21M; Venture - Series Unknown $7M–$7.4M
  • Lead/follow: 79% lead, 21% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • AppWork — We are on a mission to modernize multifamily maintenance by giving you the data you need to make informed business decisions.
  • Help Lightning — Help Lightning offers remote visual guidance software for enterprises that delivers a next generation video collaboration solution for field service.
  • Cecilian Partners — Best-in-Class Proptech Solutions: Real estate management, mapping, and development software to support property developers, home builders & realtors.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 2 investments in Canada Life Science startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 287
  • Round size: Series A $4.7M–$84M; Series B $10M–$105M; Series C $12M–$108M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Graphite Bio — Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases
  • Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
  • Nested Therapeutics — Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.
Show all investments...

Ramen Ventures
VC Fund · Toronto, Ontario, Canada · 2 investments in Canada Life Science startups

We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Canada, United States

Investor stats

  • Total investments: 22
  • Round size: Seed $1.3M–$3.2M; Pre-Seed $120k–$1.5M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
  • Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
  • Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
Show all investments...

ScaleGood Fund LP (powered by TELUS)
VC Fund · Edmonton, Alberta, Canada · 2 investments in Canada Life Science startups

Scale Good Fund is a Social Impact Venture Capital VC fund that invests in companies who have the promise of a strong financial return coupled with measurable social impact goals.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Apps
  • Stage:Seed, Pre-Seed
  • Geography: Canada

Investor stats

  • Total investments: 10
  • Round size: Seed $1.1M–$8.7M; Pre-Seed $37k–$1.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • NiaHealth — Get advanced at-home biomarker testing, proactive healthspan diagnostics, and expert guidance to elevate your health. HSA-eligible.
  • Ultimarii
  • PulseMedica — PulseMedica is developing a medical device to treat eye diseases that affect over 500 million people worldwide. Our device consists of a state-of-the-art 3D imaging and surgical platform that allows for comprehensive patient treatment.
Show all investments...

Pfizer Venture Investments
VC Fund · New York, New York, United States · 2 investments in Canada Life Science startups

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 169
  • Round size: Series A $10M–$100M; Series B $20M–$123M; Series C $15M–$102M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $600M in 2018

Portfolio highlights

  • VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
  • Ixchelsis — Ixchelsis Ltd is a clinical-stage biotechnology company developing an oxytocin receptor antagonist (IX-01) for the treatment of premature ejaculation (PE). IX-01 is a clinical stage asset that has the potential to be the best in class pharmacological approach for the treatment of PE. To date IX-01 has completed a Phase 1 single ascending dose studyin healthy male volunteers and is currently being progressed through to clinical proof of concept (POC). Ixchelsis is funded by TVM Life Sciences Ventures VII and is lead by an excellent Management team with extensive experience in pharmaceutical R&D, particularly in the male sexual health therapeutic area.
  • Flexion Therapeutics — Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
Show all investments...

Desjardins Venture Capital
VC Fund · Lévis, Quebec, Canada · 2 investments in Canada Life Science startups

Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 135
  • Round size: Seed $805k–$5M; Series A $5.7M–$22M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $120M in 2018

Portfolio highlights

  • Vention — Design and order custom industrial equipment in days. Fast and easy-to-use cloud CAD, loaded with modular parts, that ship next day.
  • Inscora — Inscora provides automated cyber risk assessment and sales enablement tools for cyber insurance brokers.
  • Vosker — Vosker provides remote area monitoring tech enabling you to take things further
Show all investments...

LVL1 Group
VC Fund · Limassol, Limassol, Cyprus · 2 investments in Canada Life Science startups

LVL1 Group is a private investment management firm, operating across different asset classes and geographies. We were founded with entrepreneurial spirit at our core, with a natural passion for venture investing, working closely with founders to forge meaningful strategic relationships and helping them to succeed. We are not bound by mandates andinvestment periods, which allows us to be flexible and opportunistic. We look for companies that aim to make a strong global impact, particularly in Online Travel, Gaming, eSports, Content and Community Platforms.

Show more...

Investment focus

  • Industry: Software, Health Care, Apps
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Seed $577k–$10M; Series A $2M–$39M; Series B $3.7M–$26M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Appetito — Buy all your groceries and household essentials from your online supermarket. Order from the comfort of your home at your finger tips.
  • GRACIA.AI — Gracia is revolutionizing spatial computing offering immersive volumetric (aka spatial) videos that provide full viewpoint freedom. This means you can step into the video and experience it from any perspective. AI-powered technology and natural parallax effects in VR enable the indistinguishable transfer of real events into the digital world,delivering a feeling of truly being there.
  • Cloud Retail — Grow your business with Jiffy SaaS platform which includes app/website, picking, delivery, supply chain & replenishment services
Show all investments...

Innovate Calgary
VC Fund · Calgary, Alberta, Canada · 2 investments in Canada Life Science startups

Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $878k–$1.9M; Pre-Seed $76k–$428k
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
  • Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
  • Possibility Neurotechnologies — Possibility Neurotechnologies develops user-centric assistive solutions to bridge the gap between advanced brain-computer interface technologies and the applications they can manage.
Show all investments...

Angel Forum
VC Fund · Vancouver, British Columbia, Canada · 2 investments in Canada Life Science startups

Founded 16 years ago in 1997, it is the only Angel Capital Forum ™ in Canada that introduces emerging companies to private equity Angel Investors. Presenting companies have raised over $35 million directly through the Forum. Read this third party blog comment and video overview. Since 1998, it has offered Investor Ready ™ workshops for companies& investors.As the oldest & largest angel network in Western Canada with 50+ investors (from Vancouver, Calgary, Edmonton, Kelowna, Victoria, Bellingham and Seattle), they are supported by leading organizations in BC and belong to Canada's National Angel Capital Organization and US's Angel Capital Association. Their private meetings are exclusive to only pre-registered Investors, selected Companies and Sponsors. Regretfully no observers except volunteers.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $20k–$500k
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Cuboh — Cuboh consolidates all your food delivery orders in one tablet and integrates them with your restaurant's POS system. Cuboh, online ordering on autopilot.
  • Truss — Send and receive business payments online with no limits, no percentage fees and no bullsh*t. Bring your business payments into the 21st century.
  • Orbitless Drive — ORBITLESS, we are pioneering the future of gear systems with our groundbreaking drivetrain technology
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Two Small Fish Ventures
VC Fund · Toronto, Ontario, Canada · 2 investments in Canada Life Science startups

Add a description for facebook

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A
  • Geography: Canada, United States, Trinidad and Tobago

Investor stats

  • Total investments: 45
  • Round size: Seed $1.8M–$16M; Series A $5.2M–$25M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $18M in 2022

Portfolio highlights

  • Haply — Haply is a robotics company that provides haptic devices, prototyping, firmware, and virtual learning assistance.
  • YScope — YScope is a software development company that provides log management and troubleshooting tools for automated failure prediction.
  • BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
Show all investments...

StandUp Ventures
VC Fund · Toronto, Ontario, Canada · 2 investments in Canada Life Science startups

StandUp Ventures is a venture capital firm investing in female-founded companies in the B2B software and digital health sector.The firm is led by a team of experienced investors who have assembled a diverse advisory committee. The advisory committee is comprised of successful founders, venture investors, and other strategic mentors who willprovide high-touch support to the entrepreneurs. StandUp Ventures catalyzes strong deal flow across Canada from its network and syndicate seed rounds with Angels and US VCs.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 46
  • Round size: Seed $1.4M–$5M; Pre-Seed $731k–$2M; Series A $2.2M–$14M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2019

Portfolio highlights

  • Wygo
  • GridBank — GridBank is a vertical video UGC library for brands that want ready-made social content without managing creators directly. It offers royalty-free, social-native videos you can search in natural language and download for use in organic and paid campaigns.
  • MintList — Find a domain name today. We make it easy.
Show all investments...

Sandpiper Ventures
VC Fund · Halifax, Nova Scotia, Canada · 1 investments in Canada Life Science startups, 6 in the past 12 months

We provide a platform where women investors and founders can radically disrupt the venture capital environment.

Show more...

Investment focus

  • Industry: Software, Wellness, Productivity Tools
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 14
  • Lead/follow: no public data

Portfolio highlights

  • SiftMed — SiftMed is an AI-first company that uses AI to help law firms, insurance companies, and Independent Medical Examiners efficiently organizse and review complex medical files.
  • QuickFacts — QuickFacts is an application that offers training, customized workflows, SaaS, insurance, digital, and software solutions.
  • Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
Show all investments...

Orchard Venture Partners
VC Fund · Chicago, Illinois, United States · 1 investments in Canada Life Science startups

OCV Partners is a Los Angeles based venture capital firm that invests in companies with differentiated technologies in compelling target markets.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series B, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 10
  • Lead/follow: no public data

Portfolio highlights

  • Verlume — Subsea energy storage and remote power generation for the energy transition, low carbon offshore operations and zero emission hydrocarbon production.
  • GUIDEcx — GUIDEcx helps you make a good first impression on your customers. A smooth, transparent customer onboarding process is key to putting your best foot forward.
  • Akebia Therapeutics — Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Show all investments...

Biofund
VC Fund · Siena, Toscana, Italy · 1 investments in Canada Life Science startups

BIOFUND SpA, established by Fondazione Monte dei Paschi, Bank Monte dei Paschi , Finanziaria Senese di Sviluppo e Fidi Toscana, provides the initial seed capital for companies located in the incubator of Toscana Life Sciences in Siena.

Show more...

Investment focus

  • Industry: Genetics, Medical, Health Care
  • Stage:Seed
  • Geography: Canada, Denmark, Russian Federation

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
  • RTM Diagnostika — Diagnostic microwave radio RTM-01-RESThe temperature and rate of growth of malignant tumorsCancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data werefirst obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous.The internal temperature - measure of angiogenesisIn 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.
  • Genizon BioSciences — Since 2005, we have helped thousands of people get the perfect domain name.
Show all investments...

Rhino Ventures
VC Fund · Vancouver, British Columbia, Canada · 1 investments in Canada Life Science startups

There is more to choosing an investor than selecting the term sheet with the highest valuation. Strategic capital, in its true form, extends the founding team’s capacity. That’s what we do at Rhino. We invest in companies where we can add tangible value. We’ve been on the other side of the table and appreciate the importance of funder and founderalignment. From startup, growth to exit; it is entrepreneurial ambition that drives value, not venture capitalists. We invest in individuals; trust and values fit are a centerpiece in every investment.

Show more...

Investment focus

  • Industry: Financial Services, Software, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, Isle of Man

Investor stats

  • Total investments: 42
  • Lead/follow: no public data

Portfolio highlights

  • MyFO — Leverage AI for effective wealth management with MyFO, making family office services attainable for all.
  • Pluto — Unlimited corporate cards with spend controls, petty cash management and automated receipt collection built for businesses in MENA (UAE, Saudi Arabia & more).
  • Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Show all investments...

Spaceship
VC Fund · 1 investments in Canada Life Science startups

Spaceship is a global group of crypto natives, founders, builders, and investors. We aim to invest in, support, and $FUEL blockchain start-ups, emerging crypto networks, and decentralized communities.

Show more...

Investment focus

  • Industry: Blockchain, Credit, Content
  • Stage:Seed, Series A
  • Geography: Canada, Portugal, United States

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Octav — Securely interpret DeFi and crypto portfolios with Octav's best-in-class cross-chain monitoring & pre-tax facilitator. Maximize efficiency for finance, accounting, tax professionals. Advanced labeling, reporting & reconciliation of DeFi investments. Latest Web3 dashboard. Elevate Decentralized Finance now.
  • Holonym — Holonym Foundation re-architects digital identity with a zero knowledge data custody network. We provide privacy-preserving tools that stop data leaks, key loss, and phishing or hacking attempts.
  • VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
Show all investments...

Rho Canada Ventures
VC Fund · New York, New York, United States · 1 investments in Canada Life Science startups

Rho Canada Ventures is a division of Rho Capital Partners focusing on early-stage investing in Canada’s most innovative technology companies.The Rho Canada Ventures team comprises a unique combination of entrepreneurial, operational, and venture investment experience in the United States and Canada. With a combined 80 years of experience, RhoCanada Ventures offers entrepreneurs the expertise to turn Canadian innovators into global leaders. Rho Canada Ventures' portfolio companies are a diverse group of investments that span new media, mobile applications, wireless infrastructure, semiconductors and materials, and software.

Show more...

Investment focus

  • Industry: Software, Analytics, Internet
  • Stage:Series A, Series B, Seed
  • Geography: Canada, United States, Italy

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • Sportlogiq — Sportlogiq is a venture-backed startup that develops sports statistics solutions. Using feeds from current broadcast cameras, the company uses player tracking and activity recognition to analyze player movement and provide context to game analysis. Sportlogiq was founded in 2014 and is headquartered in Montreal, Canada.
  • Auvik Networks — Auvik’s cloud-based network management software keeps IT networks around the world running optimally. By automating and simplifying network management, Auvik helps rocket an IT team’s efficiency and capacity, while protecting the business from network risk. Auvik is one of the fastest growing North American technology companies, and is winner ofthe Deloitte Technology Fast 50, Deloitte Fast 500, and recognized as the #1 ranked Canadian company in the FT Americas’ Fastest Growing Companies 2020. Visit www.auvik.com or follow @AuvikNetworks on Twitter. Auvik is a registered trademark of Auvik Networks Inc.
  • Resson — Resson Aerospace is a bioinformatics and data analytics company, delivering customized agriculture solutions for large corporate clients. Utilizing recent advances in large-scale cloud-based data processing, swarm robotics, and advanced data analytics, its proprietary Resson Agricultural Management and Analytics System gives the agriculturaloperator analytical insight and dynamic control over the farm area.Resson Aerospace’s Resson Agricultural Management and Analytics System, data-driven agriculture solution, analyzes crop metrics to assess crop status and health, providing operators with the information required to optimize agricultural operations, improve efficiency, boost yields, and maximize profitability. It is headquartered in Fredericton, N.B.
Show all investments...

National Research Council of Canada Industrial Research Assistance Program
VC Fund · Ottawa, Ontario, Canada · 1 investments in Canada Life Science startups

National Research Council of Canada Industrial Research Assistance Program

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: Canada, Norway, Denmark

Investor stats

  • Total investments: 110
  • Lead/follow: no public data

Portfolio highlights

  • PrePad — Simulate any well decision in seconds. PrePad empowers high-performing teams with contract-aware modeling to cut costs, save time, and maximize returns.
  • Levr.ai — Levr.ai supercharges your team with easy to implement tools that increase conversion, save time and provide a better experience for everyone.
  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
Show all investments...

Octane
VC Fund · 1 investments in Canada Life Science startups

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: Canada

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Inspire Biotherapeutics — Inspire Biotherapeutics' objective is to create curative gene therapies for those suffering from lung ailments.
Show all investments...

Life Science VC funding in Canada at a glance

Stats across 227 deals from 277 investors.

277
investors
in Canada Life Science startups
227
deals
in Canada Life Science startups
$2.5M
median round
in Canada Life Science startups
44%
lead investors
lead at least one round
28%
Seed
most common funding stage

Access all 277 VC funds in Canada Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 277 VC funds investing in Canada Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists